Pharmacy

The FINANCIAL -- Novel results based on data from the landmark EMPA-REG OUTCOME trial were published in the journal Circulation which suggest that treatment with Jardiance  positively impacts life expectancy in adults with type 2 diabetes and established cardiovascular disease, Boehringer Ingelheim and Eli Lilly and Company ...

More Articles ...

More Articles ...

The FINANCIAL -- Commenting on the Group’s sales, Roche CEO Severin Schwan said: “We have started the year with strong sales growth in both our Pharmaceuticals and Diagnostics Divisions. I am ...

The FINANCIAL -- Bayer announced on May 11 that Eylea (aflibercept solution for injection into the eye) has been approved by the Chinese regulatory authorities for the treatment of visual impairment ...

Videos

Watch the video